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Introduction
Vesicle trafficking is a fundamentally important process required 
for the exchange of proteins and lipids between organelles. 
Clathrin-coated vesicles (CCVs) are among the most abundant 
and versatile transport intermediates, which function in traffick-
ing between the trans-Golgi network and endosomes, as well 
as in endocytosis (Robinson, 2004). Knowledge of the com-
plete protein complement of different types of coated vesicles 
would significantly enhance our understanding of membrane 
traffic. In recent years, proteomics has emerged as a powerful 
tool to determine the composition of subcellular fractions, but 
the analysis of transport vesicles has remained challenging. 
Because of the transient nature and low abundance of vesicles, 
it is difficult to prepare highly enriched fractions with sufficient 
yields, so only the most prominent vesicle types have yielded to 
proteomic analysis (Bergeron et al., 2010). Many other vesicle 
coats, such as retromer (McGough and Cullen, 2011), AP-3, and 
AP-4 (Robinson, 2004), still await detailed characterization.
A general problem of fractionation-based proteomics is 
the inevitable detection of contaminants. Modern mass spec-
trometry is exquisitely sensitive and allows the identification 
of thousands of proteins from complex mixtures. However, be-
cause no subcellular fraction is ever completely pure, one can-
not objectively distinguish between proteins genuinely associated 
with the organelle of interest and copurifying contaminants. 
Uncharacterized proteins are particularly problematic in this re-
gard, and this was a limitation of early proteomic investigations 
of CCVs (Blondeau et al., 2004; Girard et al., 2005; for review 
see McPherson, 2010). Five years ago, we developed a com-
parative approach to address the issue of contaminants (Borner 
et al., 2006). Using quantitative mass spectrometry, we com-
pared CCV fractions from tissue culture cells with “mock” CCV 
fractions obtained from clathrin-depleted cells. This approach 
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Finally, we have modified our original protocol to obtain a 
CCV fraction with higher purity (Fig. S1), so the third condi-
tion was to use the older protocol. All CCV proteins are enriched 
around twofold in the improved relative to the original CCV 
fraction (Fig. 1 C).
For binary comparisons of CCV fractions, we used stable 
isotope labeling of amino acids in cell culture (SILAC; Ong 
et al., 2002) in conjunction with quantitative mass spectrometry. 
For each identified protein, a ratio of enrichment or depletion in 
the control relative to a modified CCV fraction was obtained. In 
a typical experiment, we quantified 1,000–2,000 proteins. We 
performed triplicate biological repeats of each of our three con-
ditions compared with control, as well as a further comparison 
based on fractionation properties (Fig. S1). In total, 10 datasets 
covering 2,527 proteins were acquired (Table S1).
For each dataset, proteins were sorted from highest to 
lowest ratio and plotted. CCV proteins were depleted up to 
25-fold from mock CCVs (Fig. 1 D), and enriched up to 35-fold in 
clathrin cages (Fig. 1 E), whereas most contaminants had ratios 
near one. The fractionation analysis (Fig. 1 F) shows clustering 
of CCV proteins in a narrow bracket of the plot. Hence, under 
all three conditions, known CCV proteins behaved distinctly 
from contaminants.
As a first step toward combining the three conditions, we 
plotted the fold changes of representative CCV proteins and 
contaminants for all 10 datasets (Fig. 2). For each protein, a 
characteristic profile of enrichment and depletion was obtained. 
Intracellular (AP-1) and endocytic (AP-2) CCV proteins had 
different profiles, and both were distinct from proteasomal pro-
teins. Although there was some variability between repeat exper-
iments, different subunits of the same protein complex always 
showed closely correlated behavior. This suggested that func-
tionally linked proteins might be identified by their profiles.
Merging the SILAC datasets:  
Profiling through principal component 
analysis (PCA)
We first analyzed the 688 proteins that were represented in all 10 
SILAC experiments. Each protein’s profile consisted of 10 ratios 
of enrichment or depletion. To identify groups of proteins with 
similar profiles from this unwieldy 10-dimensional dataset, we 
used PCA, a standard tool for the transformation of multivariate 
data (see “PCA” in the Materials and methods section). By re-
moving redundant linear correlations, PCA can decrease the 
dimensionality of data to a few derived super-axes termed “prin-
cipal components.” In turn, this allows the simple visual repre-
sentation of the information in two- or three-dimensional space. 
PCA is routinely used in systems biology to harness large data-
sets and perform cluster analysis (Janes and Yaffe, 2006), but has 
so far seen limited use in cell biological and proteomics applica-
tions (Dunkley et al., 2004; Hall et al., 2009). We performed 
PCA of our SILAC data with a commercially available program 
(SIMCA-P+, Umterics; see Table S4 for a step-by-step guide). 
Through the projection of the 10-dimensional SILAC data on 
the first two principal components, the dispersion of the data 
can be represented as a single scatter in only two dimensions 
(Figs. 3 and S3). Each protein is symbolized by a scatter point. 
allowed us to identify genuine CCV proteins because these 
proteins were depleted from mock CCVs. Nevertheless, owing 
to the limited dynamic range of the quantification technique 
(iTRAQ), the separation of CCV proteins from contaminants 
was suboptimal, and the list of predicted CCV proteins not 
comprehensive. We could also not exclude the possibility that 
some of the proteins depleted from mock CCVs were non-CCV 
proteins whose fractionation properties were altered by the 
clathrin knockdown. Finally, our method did not discriminate 
between endocytic and intracellular CCVs.
Here, we describe a multivariate comparative proteomics 
approach that overcomes the shortcomings of previous pro-
teomic investigations of CCVs, and also allows us to begin to 
characterize the functions of the identified proteins. The method 
is highly flexible, and can be adapted to investigate the compo-
sition of low-abundance vesicle coats and protein complexes. 
Although the focus of this study is the dissection of clathrin- 
dependent pathways, our data also shed light on the role of clathrin 
in mitosis, and include the first proteomic analysis of the retromer 
and AP-4 coats.
Results
The profiling concept
Like all subcellular fractions, our CCV-enriched fraction from 
HeLa cells is not pure. It is contaminated with abundant protein 
complexes such as ribosomes and proteasomes, as well other 
types of coated and noncoated vesicles. As we have previously 
shown, comparative proteomics of modified CCV fractions can 
be used to distinguish CCV proteins from copurifying contami-
nants (Borner et al., 2006). Building on this approach, we per-
formed multiple binary comparisons of CCV fractions prepared 
under different experimental conditions. Each comparison helps 
to identify CCV proteins, and also reveals differences between 
proteins associated with endocytic and intracellular CCVs. We 
then combined the individual datasets into a systematic “profiling 
analysis,” which classifies CCV proteins with high specificity, 
and in addition begins to group both CCV and non-CCV proteins 
according to function.
Proteomic analysis of modified CCV 
fractions by SILAC
We used three different conditions to generate modified CCV 
fractions, each of which was compared with a control CCV 
fraction. The first condition was to deplete clathrin heavy chain 
(CHC) by siRNA-mediated knockdown, thereby abolishing 
the formation of CCVs. When compared with control CCVs, 
genuine CCV proteins are depleted from this mock CCV frac-
tion, contaminants are unaffected, and intracellular CCV proteins 
are more strongly depleted than endocytic ones (Fig. 1 A; Borner 
et al., 2006). The second condition was to deplete auxilin, a protein 
involved in CCV uncoating (Eisenberg and Greene, 2007). This 
causes the cell to form membraneless cytosolic clathrin cages 
(Hirst et al., 2008), which are packed with clathrin-binding 
proteins and depleted of cargo, and which are selectively 
enriched in proteins involved in clathrin-mediated endocytosis 
relative to proteins involved in intracellular transport (Fig. 1 B). 
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The analysis achieved a striking separation of proteins 
into functional groups. Subunits of known protein complexes 
formed tight clusters, including adaptor protein (AP) complexes 
Proximity of proteins indicates similar behavior under the ex-
perimental conditions; therefore, proteins with similar profiles 
are expected to cluster.
Figure 1. Three unbiased criteria to identify CCV proteins. (A–C) Western blots of CCV fractions. (D–F) Corresponding proteomic analyses by SILAC 
and quantitative mass spectrometry. The ratio of depletion or enrichment (fold change) was calculated for each protein, and proteins were ranked from 
the highest to the lowest ratio. (A and D) Control CCV fractions compared with mock CCV fractions prepared from clathrin-depleted cells. Genuine CCV 
proteins (AP-1, AP-2, and CIMPR) are depleted from the mock fraction; contaminants (EF-2) are unchanged. The apparent depletion is more pronounced 
for AP-1 than for AP-2. (B and E) CCV/cage fractions from auxilin-depleted cells, which accumulate membraneless clathrin cages, compared with 
control CCV fractions. Endocytic proteins (AP-2 and SNX9) are enriched in the cages, whereas transmembrane cargo proteins (CIMPR) are depleted. 
(C and F) Improved CCV preparation compared with original preparation. CCV proteins are enriched approximately twofold in the improved CCV fraction 
(see also Fig. S1). To exclude the possibility that any of the changes were caused by altered transcriptional regulation, we performed a comprehensive 
microarray gene expression analysis (Fig. S2). Positions of protein molecular mass markers are indicated in kilodaltons in A–C. In some cases, the appar-
ent protein molecular weight is shown instead (indicated by ); this was estimated from the average migration of the protein relative to molecular weight 
markers on at least three gels.
JCB • VOLUME 197 • NUMBER 1 • 2012 144
proteins that were identified at least once under each of the 
three experimental conditions, and in at least four of the 10 
experiments. 1,523 proteins matched these specifications 
(Table S1), more than doubling the number of analyzable 
proteins. Custom software written in MATLAB 7.0 (Math-
Works) was then used to profile individual proteins in the 
context of a reference set. Reference proteins were repre-
sented in all 10 datasets, and belonged to six protein com-
plexes: AP-1, AP-2, AP-3, AP-4, retromer, and ribosomes. 
For each of the 1,523 candidate proteins, the algorithm first 
identified the SILAC sets in which the protein was repre-
sented. Next, it performed PCA on the reference proteins 
using only those SILAC sets. The candidate protein was then 
projected onto its reference plot, and assigned to the nearest 
cluster. Proteins assigned to either AP-1 or AP-2 were con-
sidered candidate CCV proteins (Fig. 4).
In total, the automated cluster analysis identified 136 
candidate CCV proteins. These included >93% of the known 
coat proteins detected in the CCV fraction. The assignment 
of coat proteins to either AP-1– or AP-2–positive CCVs was 
equally successful; >91% of proteins were predicted as reported 
in the literature. Furthermore, our analysis predicted 36 new 
CCV proteins (Tables 1 and S2).
Although the profiling approach was designed to identify 
CCV proteins, the tight clustering of protein complexes in Fig. 3 
1–4, COPI, BLOC-1, retromer, ribosomes, and proteasomes. 
The resolution of complexes was excellent; for example, the 
ribosomal cluster was resolved into large and small subunits 
(RPL and RPS), and the proteasomal cluster into 20S core and 
19S regulatory subunits (P20 and P19). Importantly, clathrin 
and the clathrin adaptors AP-1 and AP-2 were well separated 
from the bulk of the proteins, and clustered in the periphery 
of the plot. Known CCV cargo proteins, such as mannose 
6-phosphate receptors and lysosomal hydrolases, surrounded 
the AP-1 cluster. Moreover, established AP-1 and AP-2 bind-
ing proteins clustered closely with their respective AP complex 
(accessory factors). Based on these observations, uncharacter-
ized proteins in the vicinity of AP-1 or AP-2 are candidate new 
CCV proteins.
Automated “reference” clustering 
allows extensive profiling of proteins not 
represented in all SILAC datasets
Fig. 3 demonstrates the power of the profiling approach; how-
ever, the analysis is restricted to the 688 proteins identified in 
all 10 SILAC experiments, as PCA requires all proteins to be 
represented in every dataset. To analyze our data more com-
prehensively, we developed a novel method for processing 
SILAC ratios by PCA, which allows the inclusion of proteins 
with disparate numbers of data points. First, we selected 
Figure 2. CCV proteins and contaminants have distinct profiles. The fold changes of selected CCV proteins (AP-1 and AP-2 subunits) and copurifying 
proteasomal contaminants (PSMA1 and PSMB1) are shown for 10 SILAC datasets. Proteins that are subunits of the same protein complex have closely 
correlated profiles. Con/Cla kd 1–3: Triplicate repeats of control versus clathrin-depleted. Aux kd/Con 1–3: Triplicate repeats of auxilin-depleted versus 
control. Fractionation 1–3: Triplicate repeats of improved versus original CCV preparation. Fractionation 4*: A further comparison based on fractionation 
properties of CCVs (see Fig. S1, D and E).
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Stoichiometry of the CCV coat
SILAC data can be used to estimate the relative abundance of 
proteins through modified spectral counting (Ohta et al., 2010), 
allowing us to perform the first detailed characterization of the 
CCV coat stoichiometry (Fig. 6). Our analysis suggests that 
the vesicle inside the clathrin coat is densely covered with AP 
complexes, with approximately one AP complex per clathrin 
triskelion. The ratio of clathrin light to heavy chains is 1:3, 
intermediate to what has been reported for rat liver and brain 
CCVs (Girard et al., 2005). Surprisingly, epsinR appears to 
be as abundant as AP-1 on intracellular CCVs, and CALM as 
abundant as AP-2 on endocytic CCVs. EpsinR is a cargo adap-
tor for the endosomal Q-SNARE vti1b (Hirst et al., 2004), and 
CALM is required for the sorting of multiple R-SNAREs (Miller 
et al., 2011). These findings indicate that transport of post-Golgi 
SNAREs is a major function of CCVs.
Auxilin depletion causes sequestration  
of proteins required for cell division
Auxilin depletion not only leads to the accumulation of mem-
braneless clathrin cages, it also causes mitotic arrest (Royle, 
2011). To begin to understand the basis of the auxilin knockdown 
suggested that it may also be suitable to predict associations 
among non-CCV proteins. From the results of the automated 
profiling analysis, we predicted 15 proteins as part of the ret-
romer cluster, including 10 known and five new associations, 
and an unknown protein (C17orf56) as a potential accessory 
factor for the AP-4 complex (Table 1).
Validation of candidate CCV proteins
To test the validity of our predictions, we localized four of the 
new predicted CCV proteins (BMP2K, REPS1, FAM84B, and 
C10orf88) by immunofluorescence microscopy (Fig. 5). All 
four proteins colocalized with the clathrin adaptors AP-1 or 
AP-2 as predicted. The protein C10orf88 colocalized with 
AP-1 and AP-2 (the prediction was AP-1); this dual affiliation is 
also reflected in the PCA plot, which places the protein between 
AP-1 and AP-2, but closer to AP-1 (Fig. 4). We also localized 
a predicted new retromer protein (DENND4C), as well as the 
candidate AP-4 binding partner. DENND4C showed extensive 
colocalization with the retromer subunit VPS26, and C17orf56-
GFP colocalized very closely with AP-4 . Collectively, these 
findings strongly support the accuracy of our predictions of 
CCV and non-CCV associated proteins.
Figure 3. PCA reveals clustering of CCV and non-CCV proteins into functional groups. The SILAC data were decorrelated by PCA. The figure shows the 
projections of the data on the first (x axis) and second (y axis) principal components (scores plot). Each scatter point represents a protein. Distance from 
the origin of the plot indicates how strongly a protein is affected under the experimental conditions. Close proximity of proteins indicates similar profiles. 
Only the 688 proteins common to all 10 SILAC sets were analyzed. Subunits of a known protein complex are shown in the same color. Clathrin heavy 
and light chains, AP-1, and AP-2 form distinct clusters that and are clearly separated from the bulk of the other proteins. Known CCV coat proteins are 
annotated as AF (accessory factors). Mannose 6-phopshate receptors (M6PR) and lysosomal enzymes (Lys) are established cargo molecules of intracellular 
CCVs. A fully annotated version of this plot is shown in Fig. S3. Retro, retromer; RPS and RPL, small and large ribosomal subunits; COPI, COPI coat; CCT, 
CCT chaperone; Sig, signalosome; BLOC, BLOC-1; EIF3, translation initiation factor 3; PHK, phosphorylase kinase. P19, P20, PA: 19S, 20S, and 11S 
subcomplexes of the proteasome.
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Figure 4. Automated PCA of sample CCV proteins. Automated PCA was performed in the context of a reference set (85 proteins belonging to six protein 
complexes: AP-1, AP-2, AP-3, AP-4, retromer, and ribosomes; Table S1). For each candidate protein, PCA of the reference set was performed using only 
those datasets in which the candidate protein was represented. The candidate protein was then projected onto the corresponding PCA plot, and the near-
est reference cluster was determined. The figure shows the projections on the first two principal components for six sample proteins. The relative positions 
of reference clusters change with different combinations of available data, but in each case, all reference proteins are correctly grouped into the expected 
complexes. Candidate proteins are shown in red and reference proteins in black.
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Table 1. Vesicle proteins identified through multivariate profiling
Number CCVs Retromer AP-4
 Coat Cargo Coat Coat
 Intracellular Shared Endocytic Name Type Name Name
1 AP1B1 CLTA AP2A1 ARSA Lys VPS35 AP4B1
2 AP1G1 CLTB AP2A2 ASAH1 Lys VPS29 AP4E1
3 AP1M1 CLTC AP2B1 CTSB Lys VPS26A AP4M1
4 AP1S1 CLTCL1 AP2M1 CTSC Lys VPS26B AP4S1
5 AP1S2 BCL9L AP2S1 CTSD Lys DENND4C* C17orf56/
6 AP1S3 C10orf88* AAK1 CTSL1 Lys FNBP1L Tepsin*
7 AFTPH DERPC AAK1A CTSZ Lys NSF
8 AP1GBP1 DNAJC6/Aux1 AGFG1 DNASE2 Lys PACSIN2
9 ARF1 DNM2 ARRB2 EPDR1 Lys PI4K2B
10 C4orf16 DNMBP BIN3 GGH Lys SNX2
11 CLINT1 EIF2C2 BMP2K* GLB1 Lys SNX3
12 FAM84B* FAM109A CLLD6 GNS Lys SNX5
13 GGA2 FAM109B DAB2 HEXB Lys SNX6
14 HEATR5B GAK/Aux2 DENND1A LIPA Lys TBC1D4
15 MLK4 HIP1R EPN1 MAN2B1 Lys TBC1D5
16 RAB4A NAPA EPN2 NEU1 Lys
17 RAB4B NAPG EPS15 NPC2 Lys
18 RABGEF1 NCOA3 EPS15L1 PLBD2 Lys
19 SCYL2 OCRL FAM21A PLOD1 Lys
20 SNX24 PIK3C2A FCHO2 PLOD2 Lys
21 TRIM47 PLEKHJ1 GAPVD1 PPGB Lys
22 VPS45 PUM1 HIP1 PPT2 Lys
23 STAMBPL1 ITSN1 PSAP Lys
24 TNRC6A KIAA0196 TPP1 Lys
25 TNRC6B LDLRAP1 STX6 SNARE
26 MAP3K7IP1 STX7 SNARE
27 MEA1 STX8 SNARE
28 NECAP1 STX10 SNARE
29 NECAP2 STX16 SNARE
30 NUMB VTI1A SNARE
31 NUMBL VTI1B SNARE
32 PICALM VAMP4 SNARE
33 PTPN23 ABCA2 TMD
34 PUM2 ANKH TMD
35 RALBP1 ATP2C1 TMD
36 REPS1* ATP7A TMD
37 SMAP1 FAM18B TMD
38 SNX9 HFE TMD
39 STAMBP IGF2R TMD
40 STON2 M6PR TMD
41 SYNJ1 SCAMP2 TMD
42 TNK2 SORT1 TMD
43 TSPAN13 TMD
44 VLDLR TMD
45 YIPF6 TMD
46 GRN Lumenal
47 HSPA13 Lumenal
New predicted CCV-, retromer-, or AP-4-associated proteins are shown in bold. Known clathrin coat components were classified as localizing to intracellular, endo-
cytic, or both types of CCVs (“shared”), based on published evidence (Table S2). New clathrin coat proteins were categorized as predicted in this study. Lysosomal 
enzymes (Lys) are cargo proteins of intracellular CCVs. Most transmembrane cargo proteins are trafficked by both intracellular and endocytic CCVs, and hence do not 
have an unambiguous known affiliation. For retromer- and AP-4–associated proteins, the analysis was restricted to coat proteins, and is likely to be less comprehensive 
than for CCV proteins. Asterisks indicate subcellular localization confirmed by microscopy (Fig. 5). TMD, transmembrane domain.
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had not been included in the CCV profiling analysis because 
they were detectable only in auxilin-depleted cells, due to their 
increased abundance. One such protein is TACC3, which func-
tions in cell division and which normally forms a complex with 
clathrin and two other proteins, GTSE1 and CKAP5/chTOG, 
phenotype, we devised a simple profiling approach to determine 
the protein composition of the clathrin cages. Merging the data 
from all three auxilin depletion SILAC sets, we identified a 
group of 104 proteins that were consistently enriched (4–30-fold) 
in the clathrin cage fraction (Table S3). Many of these proteins 
Figure 5. Subcellular localization of predicted 
new CCV, retromer, and AP-4–associated pro-
teins. The proteins shown in Fig. 4 were local-
ized by immunofluorescence microscopy. In the 
case of REPS1, the endogenous protein was de-
tected with a specific antibody. Other proteins 
were myc- or GFP-tagged as indicated, and 
transiently expressed. Colocalization with in-
tracellular or plasma membrane clathrin-coated 
structures was investigated by double labeling 
with antibodies against AP-1  or AP-2 , re-
spectively. C10orf88-myc colocalizes with AP-1 
and AP-2, which necessitated imaging in two 
different focal plains. For reasons of antibody 
compatibility, CALM was used in this case to 
define clathrin-coated structures at the plasma 
membrane. Overlays show new proteins in red 
and reference proteins in green. Bars: (large 
panels) 10 µm; (insets) 2 µm.
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CKAP5 all had enrichment profiles similar to clathrin and other 
coat components in the auxilin-depleted cells, but behaved like 
non-CCV proteins in control cells (Fig. 7 C). These data in-
dicate that TACC3, GTSE1, and CKAP5 are not constituents 
of normal CCVs. However, in auxilin-depleted cells, they be-
come sequestered in clathrin cages, and are hence not avail-
able during mitosis. Consistent with this hypothesis, auxilin 
depletion caused a strong reduction in the levels of TACC3 
associated with mitotic spindles (Fig. 7 D).
Two recent reports show that auxilin depletion results in 
cell cycle arrest and chromosomal missorting (Shimizu et al., 
2009; Tanenbaum et al., 2010). Because clathrin itself is also 
important for mitosis, the authors hypothesized that in the absence 
of auxilin, a lack of clathrin recycling caused the mitotic defects. 
on the mitotic spindle (Hubner et al., 2010; Booth et al., 2011). 
GTSE1 and CKAP5 are also highly enriched in the clathrin 
cages (Fig. 7 A), which suggests that cage formation and mitotic 
arrest may be causally linked.
We first tested by Western blotting whether hyperenrich-
ment of these proteins in the cage fraction was a consequence 
of altered protein expression or stability (Fig. 7 B). Overall 
expression levels of TACC3 and CKAP5 were unaffected by 
auxilin knockdown. Both proteins are barely detectable in con-
trol CCVs, but are highly enriched in the clathrin cage fraction. 
To ensure that the proteins were actually components of the 
clathrin cages, we next compared cage fractions prepared using 
the original and the improved preparation protocol by SILAC 
(as in Fig. 1, C and F). We found that TACC3, GTSE1, and 
Figure 6. Estimated stoichiometry of clathrin 
coats. To estimate the abundance of major 
CCV proteins in the CCV fraction, emPAIs were 
calculated from the SILAC data (Table S1) and 
normalized to CHC (relative emPAI = 1). The 
approximate number of copies of each protein 
in a “typical” CCV with 40 triskelia (Cheng 
et al., 2007) is also indicated. Error bars indi-
cate SD (n = 3). (A) Relative abundance of APs 
and clathrin. For every CHC molecule, there 
are 0.3 light chains (CLT A + B) and 0.3 
AP complexes. AP-1 is approximately twice as 
abundant as AP-2, which suggests that 2/3 
of the CCVs in the preparation are intracellular, 
and 1/3 are endocytic. (B) Estimated compo-
sition of the intracellular CCV coat, assuming a 
CHC/AP-1 ratio of 3:1. There may be more 
than one type of intracellular CCV; the figure 
shows the estimates for a hypothetical average 
CCV. (C) Estimated composition of the endo-
cytic CCV coat, assuming a CHC/AP-2 ratio 
of 3:1. Asterisks indicate shared proteins.
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Figure 7. Auxilin depletion causes sequestration of mitotic spindle proteins in clathrin cages. (A) Representative SILAC analysis of CCV fractions from 
control and auxilin-depleted cells, as performed in Fig. 1 E. The ranks of TACC3, GTSE1, and CKAP5 are indicated. (B) Western blot of whole cell 
lysates and CCV fractions corresponding to A. TACC3 and CKAP5 are barely detectable in control CCV fractions but highly enriched in CCV fractions 
from auxilin-depleted cells. In contrast, typical CCV proteins such as SNX9 are readily detectable in control CCVs. MHC-I is shown as a loading control. 
151Multivariate coated vesicle profiling • Borner et al.
(C) Fractionation behavior of CKAP5, TACC3, and GTSE1 in control (left) and auxilin-depleted cells (right). In both cases, fractions were prepared using the 
original or the improved protocol, and compared by SILAC as in Fig. 1 F. CKAP5, GTSE1, and TACC3 (which was undetectable under control conditions) 
fractionate like clathrin-associated proteins only in auxilin-depleted cells, which indicates a specific association with clathrin cages. (D) Auxilin depletion 
causes loss of TACC3 from the mitotic spindle in HeLa cells. Bars, 10 µm. (E) HeLa cells were depleted of auxilin, clathrin, or both, or treated with a non-
targeting siRNA (control), then stained with Hoechst to visualize DNA. Micronuclei (arrowheads) were detected by automated microscopy. Representative 
images are shown. Bar, 20 µm. (F) Relative changes in the proportion of micronucleated cells, normalized to nontargeting siRNA-treated cells (control). 
Error bars show the SEM of four independent repeats (three repeats for untreated cells). (G) Binary comparisons of the treatment groups shown in F, using 
ANOVA and the post-hoc Tukey-Kramer significance test. The difference between auxilin depletion and combined clathrin/auxilin depletion is highly signifi-
cant (P < 0.001). The total number of cells scored for every condition is indicated. *, P < 0.05; **, P < 0.01; ***, P < 0.001. (H) Corresponding Western 
blot analysis of cell lysates. Clathrin and auxilin (isoforms 1 and 2) were effectively depleted in the individual and the combined knockdowns. Positions of 
protein molecular mass markers are indicated in kilodaltons in B and H. In some cases, the apparent protein molecular weight is shown instead (indicated 
by ); this was estimated from the average migration of the protein relative to molecular weight markers on at least three gels.
 
However, this hypothesis does not explain why the phenotype 
of auxilin depletion is more severe than that of clathrin deple-
tion. Our finding that TACC3, GTSE1, and CKAP5 are seques-
tered into clathrin cages suggests the alternative hypothesis that 
auxilin depletion deprives cells not only of free cytosolic clath-
rin, but also of other proteins required for mitosis. If the first 
hypothesis is correct, then a combined depletion of clathrin and 
auxilin should be additive, because the trace amounts of clath-
rin remaining after a clathrin knockdown would be prevented 
from accessing the spindle. However, if our hypothesis is cor-
rect, then the combined depletion should result in a less severe 
phenotype than auxilin depletion alone, as the lack of clathrin 
would prevent the formation of cages, and hence liberate TACC3, 
GTSE1, and CKAP5.
To test these hypotheses, we analyzed mitotic defects in 
clathrin- and auxilin-depleted cells by automated fluorescence 
microscopy (Fig. 7 E). We determined the proportion of micro-
nucleated cells, which is a standard measure of chromosome 
misalignment and mitotic slippage (Schneider et al., 2007). 
Clathrin depletion caused a moderate increase (2.4-fold), and 
auxilin depletion caused a strong increase (6.5-fold) in the 
number of micronucleated cells (Fig. 7, F and G). The joint 
depletion of clathrin and auxilin significantly improved mitotic 
fidelity relative to auxilin depletion alone (4.1-fold increase in 
micronucleated cells). Thus, clathrin depletion can substantially 
override the effects of auxilin depletion, which is consistent 
with our hypothesis that auxilin depletion causes sequestration 
of TACC3 and associated proteins in clathrin cages.
Tepsin: The first AP-4 accessory protein
Although our experiments were designed to identify CCV pro-
teins, the PCA profiling also provides insights into other trans-
port intermediates, including AP-4–coated vesicles. AP-4 was 
first described 13 years ago and has recently gained prominence 
because of its links with Alzheimer’s disease and other neuro-
logical disorders (Verkerk et al., 2009; Burgos et al., 2010; 
Abou Jamra et al., 2011). However, to date no cytosolic AP-4–
associated proteins have been identified. The finding that an un-
characterized protein, C17orf56, coclusters with AP-4 subunits 
(Fig. S4) prompted us to investigate this protein further.
Bioinformatic analysis of C17orf56 revealed that it has an 
epsin N-terminal homology (ENTH) domain, most closely re-
lated to that of epsinR (Hirst et al., 2004), so we have named the 
protein “tepsin” (tetra-epsin). Like AP-4, tepsin is evolutionarily 
ancient and is found in all five eukaryotic supergroups (Fig. 8 A). 
Both AP-4 and tepsin have been concomitantly lost from sev-
eral organisms including yeast, worms, and flies. This suggests 
that AP-4 and tepsin depend upon each other for function. 
To explore the relationship between AP-4 and tepsin further, we 
used fibroblasts from patients with mutations in either the 
 or the µ subunit of AP-4 (AP4B1*, Abou Jamra et al., 2011; 
AP4M1*, Verkerk et al., 2009), both of which result in prema-
ture stop codons (see Materials and methods). The very similar 
phenotypes of the patients indicate that both mutations inac-
tivate the AP-4 complex. Western blots of cell homogenates 
showed reduced levels of other AP-4 subunits in cells from the 
AP-4–deficient patients, whereas tepsin levels were unchanged. 
However, both AP-4 and tepsin were undetectable in coated 
vesicle fractions from the patients’ cells (Fig. 8 B). As shown 
by immunofluorescence, tepsin has a punctate juxtanuclear 
pattern in control fibroblasts as well as in primary neurons 
(Fig. 8, C and D), which colocalizes extensively with AP-4. 
This pattern is completely absent in fibroblasts from AP-4– 
deficient patients (Fig. 8 D), which suggests that tepsin requires 
AP-4 for membrane recruitment. Furthermore, tepsin was co-
immunoprecipitated with AP-4  in extracts from control cells, 
but not in extracts from AP4M1* patient cells, even though the 
residual large AP-4 subunits,  and 4, were still coimmuno-
precipitated (Fig. 8 E). This indicates that tepsin interacts only 
with functional AP-4.
To further investigate this association, we prepared coated 
vesicle fractions from HeLa cells depleted of either AP-4 or 
tepsin (Fig. 8 F). AP-4 depletion resulted in loss of both AP-4 
and tepsin from the vesicle fraction. Conversely, depleting tep-
sin did not affect the yield of AP-4 in the vesicle fraction, which 
indicates that AP-4 recruits tepsin rather than vice versa. To 
identify the binding domain on AP-4 for tepsin, we performed 
GST pull-downs using the C-terminal “ear” domains of the two 
large subunits as bait, chosen because most of the accessory 
proteins that associate with AP-1 or AP-2 do so by interacting 
with one or both of the ears. We found that GFP-tagged tepsin 
specifically interacts with the 4 ear (Fig. 8 G). We indepen-
dently confirmed this result by mass spectrometric analysis of 
AP-4–ear pull-downs performed in nontransfected HeLa cells 
(Fig. 8 H). Thus, tepsin is the first reported ear binding partner 
for any of the non–clathrin-associated AP complexes.
Finally, we explored the dynamics of the AP-4 coat for 
the first time by carrying out live cell imaging on cells express-
ing tepsin-GFP (Video 1). Tepsin-GFP puncta were highly 
mobile, and some appeared to move from the perinuclear area to 
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Figure 8. Characterization of tepsin, a new AP-4–associated protein. (A) Schematic diagrams of tepsin from organisms belonging to all five eukaryotic 
supergroups. All tepsins have an N-terminal ENTH domain and a central VHS/ENTH-like domain. (B) Western blots of whole cell lysates and coated vesicle 
(CV) fractions from primary human fibroblasts. Tepsin has two isoforms. Although the total amount of tepsin is unchanged in cells with mutations in the AP-4 
 and  subunits (AP4B1* and AP4M1*, respectively), the tepsin no longer co-fractionates with coated vesicles. (C) Immunofluorescence double labeling 
153Multivariate coated vesicle profiling • Borner et al.
the cell periphery. This indicates that the AP-4 vesicles and/or 
the compartments from which they bud are capable of vectorial 
long-distance transport.
Discussion
Multivariate profiling maps CCV-dependent 
pathways with unprecedented accuracy
In this study, we developed a multivariate comparative proteomics 
approach to characterize clathrin-dependent pathways in HeLa 
cells. We established several conditions for generating modified 
CCV fractions, and compared these by quantitative mass spec-
trometry. Combination of our data through automated PCA pro-
filing allowed the unbiased high-confidence identification and 
classification of both CCV and non-CCV proteins.
Our analysis identified 136 CCV proteins (89 coat and 
47 cargo proteins), including 55 of the 59 known coat proteins 
present in the CCV fraction (Table S2), which suggests that the 
profiling approach provided near-complete coverage of CCV 
proteins expressed in HeLa cells. The four known CCV proteins 
that were missed are Rab5a–c and -arrestin 1. Rab5 localizes 
mostly to endosomes (Stenmark, 2009), whereas arrestins 
become incorporated into CCVs only upon stimulus (Traub, 
2009). Hence, these proteins are not predominantly associated 
with CCVs, and this was reflected in our analysis. In addition, 
our list of predicted CCV proteins is completely free of typical 
contaminants, such as ribosomal proteins. The four predicted 
CCV proteins chosen for validation showed significant or com-
plete colocalization with clathrin adaptors, which suggests that 
the number of false positive predictions is likely to be small. 
Collectively, these data show that the profiling approach pro-
vides a comprehensive analysis of CCV proteins in HeLa cells.
A further novel feature of the profiling approach is the 
unbiased assignment of proteins to endocytic or intracellular 
CCVs. Our analysis correctly predicted the association of 42 out 
of 46 known CCV coat proteins (only proteins with an estab-
lished unambiguous endocytic or intracellular association were 
scored; Table S2). The 25 predicted new CCV coat proteins 
can therefore be classified with high confidence.
Among the predicted new CCV proteins are three compo-
nents of the RNA-induced silencing complex (RISC): TNRC6A/
GW182, TNRC6B, and Argonaute-2/EIF2C2. Their profiles in-
dicate that these proteins may associate with both intracellular 
and endocytic CCVs. Because RISC is required for RNA pro-
cessing, this was certainly an unexpected finding. Nevertheless, 
preliminary GST pull-down experiments show that all three 
proteins can interact with AP-1 (unpublished data), and a recent 
report shows that the closely related protein TNRC6C can 
coprecipitate clathrin, AP-1, and AP-2 (Chekulaeva et al., 2011). 
Our data therefore suggest that CCVs are involved in regulating 
RISC function or localization.
Finally, our cluster analysis also allowed us to investigate 
the behavior of proteins whose association with CCVs is con-
troversial. For instance, the AP-3 complex has been proposed 
to interact with clathrin (Dell’Angelica, 2009), but our data in-
dicate that this is not the case in HeLa cells. The relationship 
between clathrin and retromer is also unclear (McGough and 
Cullen, 2011), and in our previous study, we found a partial 
depletion of retromer from the CCV fraction when clathrin was 
depleted. Here we find that retromer and CCVs do not cofraction-
ate (Fig. S1), and in the profiling analysis (Fig. 3) the retromer 
complex forms a distinct cluster relatively close to the AP-1 
cluster. Thus, although we cannot rule out the possibility that 
there might be two pools of retromer, one associated with CCVs 
and one not, our data indicate that for the most part, clathrin and 
retromer are not part of the same transport intermediate.
Limitations of the profiling approach
The profiling approach is likely to miss proteins whose associa-
tion with CCVs is very transient, or which are mostly associated 
with another organelle. This is particularly relevant for cargo 
proteins, such as the transferrin receptor, which occupy CCVs 
only in transit, and which therefore have different profiles from 
proteins that are mainly associated with CCVs at steady-state. 
As a result, the list of CCV cargo proteins identified here is 
likely to be incomplete. Furthermore, our analysis discriminates 
only between endocytic and intracellular CCVs. There are prob-
ably multiple types of intracellular CCVs, which may rely on 
different APs, such as GGAs and AP-1 (Robinson, 2004). Al-
though we have attempted to interfere with the formation of 
AP-1–positive CCVs, knockdown of AP-1 had surprisingly little 
effect on CCV composition, possibly because of up-regulation 
of compensatory pathways (unpublished data). A more informa-
tive approach may be to use acute depletion of AP-1 or GGAs 
by drug-induced “knocksideways” (Robinson et al., 2010), and 
we are currently exploring this possibility.
Auxilin knockdown causes sequestration  
of proteins required for cell division
Auxilin depletion causes cell cycle arrest in a pro-mitotic state, 
whereas clathrin depletion results in a milder phenotype. Here, 
we provide a simple explanation for this puzzling observa-
tion. Auxilin depletion causes the accumulation of cytosolic 
clathrin cages, which are packed with clathrin-binding proteins. 
for tepsin and the AP-4  subunit in a primary cortical rat neuron. The two proteins show extensive colocalization. Bar, 10 µm. (D) Immunofluorescence 
double labeling for tepsin and AP-4  in primary human fibroblasts. Although the two proteins colocalize in a punctate perinuclear pattern in control cells, 
this pattern is absent in AP-4–deficient cells. Bar, 10 µm. (E) Western blots of immunoprecipitates of the AP-4  subunit from extracts of control and 
AP-4–deficient fibroblasts, probed for AP-4 subunits and tepsin. Tepsin coimmunoprecipitates with AP-4 only in the control extracts. (F) PNS and coated 
vesicle fraction from control, AP-4–depleted, and tepsin-depleted HeLa cells. Although tepsin requires AP-4 for incorporation into coated vesicles, AP-4 can 
still be incorporated in the absence of tepsin. (G) GST pull-downs from tepsin-GFP–expressing HeLa cells. Tagged tepsin specifically interacts with the 
AP-4  “ear” domain. (H) GST pull-downs from HeLa cells were analyzed by mass spectrometry. Peptides, unique matched peptides; count, total number 
of matched peptides. Tepsin is only pulled down with the AP-4  ear. Positions of protein molecular mass markers are indicated in kilodaltons in B and 
E–G. In some cases, the apparent protein molecular weight is shown instead (indicated by ); this was estimated from the average migration of the protein 
relative to molecular weight markers on at least three gels.
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cases of familial intellectual disability and spastic paraplegia 
where the responsible gene has not yet been identified, and it 
will be important to determine whether any of these patients 
have mutations in the tepsin gene.
Why was tepsin not discovered earlier? The most likely 
explanation is that only small amounts of tepsin are present in 
AP-4 immunoprecipitations and GST pull-downs, together with 
a high background of nonspecific proteins. In addition, we suspect 
that tepsin only associates with AP-4 when it is productively in-
volved in vesicle formation. Two observations support this hy-
pothesis: first, tepsin does not appear to coimmunoprecipitate 
with defective AP-4 complexes, even though these complexes 
contain the 4 appendage to which it binds (Fig. 8 E). Second, 
Western blots of tepsin and AP-4 immunoprecipitates indicate 
that at steady-state, most of the AP-4 and tepsin are in separate 
pools, yet spectral counting indicates that they have similar stoichi-
ometries in our coated vesicle fraction (unpublished data). Thus, 
tepsin is similar in this regard to epsinR and CALM, which are 
major components of AP-1– and AP-2–positive CCVs, respec-
tively, but which are not tightly associated with cytosolic AP 
complexes. Because our method is designed to isolate transport 
intermediates, we are able to detect physiologically relevant inter-
actions that may be missed using more conventional approaches.
Perspective: PCA-based vesicle profiling
This study represents the most comprehensive and stringent 
analysis of the CCV proteome to date. In addition, it provides 
a conceptually novel and advantageous approach to subcellular 
proteomics. Multivariate profiling renders organelle purity much 
less critical than in primarily fractionation-based proteomics. 
Here, CCVs were characterized with high sensitivity and speci-
ficity in the presence of >90% background proteins, allowing 
the first detailed characterization of CCVs from human cells. 
Compared with other comparative proteomics approaches (e.g., 
Ohta et al., 2010), profiling through PCA is computationally 
straightforward. Construction of basic PCA projections, such 
as the scatter plot in Fig. 3, involves minimal processing of the 
SILAC data, does not require specialist knowledge, and is read-
ily performed with commercially or freely available software. 
We encourage readers to recreate Fig. 3 with the step-by-step 
guide provided in the supplemental data (Table S4) to convince 
themselves of the simplicity of the procedure.
A further advantage of the present approach is that the 
PCA is blind to the candidate dataset and hence requires no 
prior training with the proteins of interest, circumventing the 
need for a large training dataset. Moreover, in introducing auto-
mated “reference” clustering, we have shown how PCA-based 
profiling can accommodate proteins with disparate numbers of 
data points, a problem that has so far restricted the usefulness of 
PCA in proteomic applications. Finally, the study also high-
lights how the sensitivity of the approach extends to other coated 
vesicles that were not the primary target of the investigation. As a 
byproduct of CCV profiling, we describe here the first compo-
sitional analysis of the AP-4 coat, which has so far defied bio-
chemical purification because of its low abundance. The method 
may be refocused, for example, by replacing clathrin knock-
downs with AP-4 knockdowns, by using different fractionation 
Our profiling analysis shows that these binding partners include 
the mitotic spindle protein TACC3, which stabilizes micro-
tubules. Under control conditions, TACC3 recruits free clathrin 
to the mitotic spindle (Booth et al., 2011); however, in auxilin- 
depleted cells, clathrin is aggregated into cages, which provide a 
relatively immobile, high-affinity binding surface. Therefore, 
TACC3 and its binding partners CKAP5 and GTSE1 become 
trapped in the clathrin cages, and are no longer available to sta-
bilize spindle microtubules, resulting in severe mitotic defects. 
We tested this model by quantifying micronucleation in cells 
depleted of auxilin and clathrin. As predicted, clathrin depletion 
substantially reversed the effects of auxilin depletion. The in-
complete rescue may be explained by timing effects during the 
96-h knockdown. Because clathrin is a very stable and abundant 
protein, auxilin depletion is likely to precede clathrin depletion. 
Hence, clathrin cages will form initially and cause some micro-
nucleation before clathrin depletion overrides the auxilin phe-
notype. In addition, it appears that the knockdown efficiency for 
clathrin may be slightly reduced in the combined clathrin/auxilin 
depletion (Fig. 7 H).
Finally, it is worth noting that the increase in the propor-
tion of micronucleated cells in auxilin-depleted cells described 
here (6.5-fold) is very similar to that observed in TACC3- 
depleted cells (6-fold; Schneider et al., 2007). This further 
suggests that sequestration of TACC3 and associated proteins 
accounts for the auxilin mitosis phenotype.
Profiling of non-CCV proteins
Although our experimental conditions were optimized for CCV 
proteins, a byproduct of the profiling is a comprehensive cluster 
analysis of non-CCV proteins, which constitute the vast major-
ity of the proteins present in the CCV fraction. In particular, 
stable protein complexes such as ribosomes and proteasomes, 
as well as non-clathrin vesicle coats, such as COPI, retromer, 
AP-3, and AP-4, are identified as tight clusters in Fig. 3. The 
discriminating power is highest for peripheral clusters, and cen-
tral clusters are likely to overlap with functionally unrelated 
proteins. Nevertheless, the plot provides candidate interacting 
proteins for all present complexes. As a proof of principle, we 
used the profiling data to predict retromer and AP-4–associated 
proteins. For retromer, 10 known and five new components were 
predicted, and we substantiated the predictions by colocalizing 
one of the new proteins, DENND4C, with retromer. DENND4C 
is a guanine nucleotide exchange factor for the endosomal 
GTPase Rab10 (Yoshimura et al., 2010), and thus is potentially 
an important new regulator of retromer-mediated trafficking.
We also identified the first cytosolic AP-4–associated 
protein reported to date, an ENTH domain–containing protein 
that we have named tepsin. The importance of AP-4, in particu-
lar in neurons, is highlighted by several recent studies. First, 
the Alzheimer’s disease protein, APP, has been shown to inter-
act with AP-4, and there is evidence that its trafficking is AP-4 
dependent (Burgos et al., 2010). In addition, several patients 
have been identified with mutations in each of the four AP-4 
subunits who present with severe intellectual disability and pro-
gressive spastic paraplegia (Verkerk et al., 2009; Abou Jamra 
et al., 2011; Moreno-De-Luca et al., 2011). There are many 
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REPS1 (rabbit pAb; this study), and tepsin (rabbit pAb; this study). The 
REPS1 antibody was raised against an N-terminal GST fusion protein cor-
responding to a central part of REPS1 (isoform 2): LEDSADVGDQPGEV-
GYSGSPAEAPPSKSPSMPSLNQTWPELNQSSEDTAIVHPVPIRMTPSKIHMQ-
EMELKRTGSDHTNPTSPLLVKPSDLLEENKINSSVKFASGNTVDG. The cDNA 
used for cloning was Integrated Molecular Analysis of Genomes and their 
Expression (IMAGE) clone no. 5754186. The specificity of the Reps1 anti-
body was verified by siRNA knockdown. The tepsin antibody was raised 
against an N-terminal GST fusion protein corresponding to a C-terminal 
fragment of the long (525 aa) tepsin isoform: DLSRVSDSGSHSGSDSHSG-
ASREPGDLAERVEVVALSDCQQELSLVRTVTRGPRAFLSREEAQHFIKACGLL-
NCEAVLQLLTCHLRGTSECTQLRALCAIASLGSSDLLPQEHILLRTRPWLQELS-
MGSPGPVTNKATKILRHFEASCGQLSPARGTSAEPGPTAALPGPSDLLTDAVP-
LPGSQVFLQPLSSTPVSSRSPAPSSGMPSSPVPTPPPDASPIPAPGDPSEAEAR-
LAESRRWRPERIPGGTDSPKRGPSSCAWSRDSLFAGMELVACPRLVGAGA-
AAGESCPDAPRAPQTSSQRTAAKE. The cDNA used for cloning was IMAGE 
clone no. 5430837. The tepsin antibody recognizes both isoforms (pre-
sumably splice variants) of the protein (apparent molecular masses are 
65 and 72 kD). Both bands are sensitive to siRNA knockdown of tepsin, 
demonstrating the specificity of the antibody (Fig. 8 F). HRP-linked second-
ary antibodies were purchased from Sigma-Aldrich, and fluorescently labeled 
secondary antibodies were from Invitrogen. Hoechst 33342 (Invitrogen) 
was used to stain DNA.
Preparation of CCV-enriched fractions
Control CCV-enriched fractions were prepared as described previously 
(Borner et al., 2006), with several minor modifications. The most impor-
tant improvement is the reduced speed of the final pelleting step, which 
increases the purity of CCVs approximately twofold relative to our pre-
viously published protocol. The following is a brief summary of the 
“improved” protocol:
Four confluent dishes (500 cm2 each) of HeLa cells were scraped 
into 10 ml of buffer A (0.1 M MES, pH 6.5 [adjusted with NaOH], 
0.2 mM EGTA, and 0.5 mM MgCl2). Cells were homogenized with a 
motorized Potter-Elvehjem homogenizer (20 strokes), and centrifuged at 
4,100 g for 32 min. Supernatants were treated with ribonuclease A 
at 50 µg/ml for 60 min. Partially digested ribosomes were pelleted by 
centrifugation (4,100 g for 3 min), and discarded. Membranes were 
pelleted by centrifugation at 55,000 rpm (209,900 g RCFmax) for 40 min 
in an MLA-80 rotor (Beckman Coulter). Membranes were resuspended 
in 800 µl buffer A using a 1 ml Dounce homogenizer, and mixed with 
an equal volume of FS buffer (12.5% [wt/vol] Ficoll and 12.5% [wt/vol] 
sucrose, in buffer A). All subsequent centrifugation steps were performed 
with a TLA-110 rotor (Beckman Coulter). Samples were spun at 20,000 rpm 
(21,700 g RCFmax) for 34 min to pellet the bulk of the non-CCV mem-
branes (pellet discarded). Supernatants were diluted with four volumes 
of buffer A, and centrifuged at 20,000 rpm (21,700 g RCFmax) for 15 min 
to pellet contaminating glycogen particles (pellet discarded). Superna-
tants were centrifuged at 35,000 rpm (66,500 g RCFmax) for 30 min 
to obtain the CCV-enriched fraction (pellet). All preparations were per-
formed at 4°C.
Mock CCV fractions and clathrin-cage enriched fractions were pre-
pared likewise, but from 8–16 confluent dishes (177 cm2 each) of HeLa 
cells that had been treated with siRNA against CHC, or auxilin 1 and 
auxilin 2, respectively. “Original” CCV fractions were also prepared as 
above, but the glycogen pelleting step was omitted, and the final pelleting 
step was performed at 60,000 rpm (195,500 g RCFmax) for 30 min.
Comparison of CCV fractions by quantitative mass spectrometry
CCV-enriched fractions were resuspended in small volumes (100 µl) 
of nonreducing SDS buffer (4% [wt/vol] SDS and 10 mM Tris-HCl, 
pH 8.0), heated to 65°C for 3 min, and centrifuged at 16,000 g for 
1 min to pellet insoluble material. Samples were stored at 70°C 
until further use. Protein concentrations were estimated with a BCA assay 
(Thermo Fisher Scientific).
For binary comparisons, CCV fractions prepared from metabolically 
labeled and unlabeled cells were pooled (20–50 µg protein per fraction; 
equal amounts pooled). Samples were adjusted with 1:3 volumes of 4× 
sample buffer (10% [wt/vol] SDS, 40% [vol/vol] glycerol, 8% [vol/vol] 
2-mercaptoethanol, and 200 mM Tris-HCl, pH 6.8), reduced at 90°C for 
3 min, and separated in a single lane by SDS-PAGE. Gels were stained 
with Coomassie blue, and each lane was cut into 20 slices. Proteins were 
reduced, alkylated with iodoacetamide (no. A3221; Sigma-Aldrich), and 
in-gel digested with trypsin. A detailed protocol can be found in Antrobus 
and Borner (2011).
protocols, or by adding small molecules to perturb a particular 
pathway. In principle, by choosing suitable conditions, the pro-
filing approach can be adapted to characterize any subcellular 
fraction, from any cell type, and thus provides a universal tool 
for mapping protein–protein interactions.
Materials and methods
Cell culture, metabolic labeling, and siRNA-mediated knockdowns
For two-way comparison SILAC experiments, HeLaM cells (Tiwari et al., 
1987) were cultured in DME (Sigma-Aldrich) supplemented with 10% 
(vol/vol) fetal calf serum (Sigma-Aldrich), or in SILAC medium (Thermo-
Fisher Scientific) supplemented with 10% (vol/vol) dialyzed fetal calf serum 
(10,000 MW cut-off; Invitrogen) and “heavy” amino acids (l-arginine-
13C615N4:HCl [50 mg/liter] and l-lysine-13C615N2:2HCl [100 mg/liter]; 
Cambridge Isotope Laboratories) for 7 d to achieve metabolic labeling. 
The mean incorporation efficiency was 97%, as determined by liquid 
chromatography-tandem mass spectrometry (LC-MSMS). For the three-way 
comparison SILAC experiment, cells were grown in DME as above, or 
in SILAC medium supplemented with “medium heavy” l-arginine-13C6 and 
l-lysine-4,4,5,5-D4 (Cambridge Isotope Laboratories), or in SILAC medium 
supplemented with “heavy” l-arginine-13C615N4 and l-lysine-13C615N2, for 
7 d. SILAC medium was always supplemented with 200 mg/liter l-proline 
(Sigma-Aldrich). DME and SILAC medium were supplemented with anti-
biotics (penicillin/streptomycin; no. P0781; Sigma-Aldrich) according to the 
manufacturer’s instructions. In all SILAC experiments, cells used for control 
CCV preparations were grown in “heavy” labeled SILAC medium.
All siRNA oligos were purchased from Thermo Fisher Scientific. 
Knockdown of auxilin 1/DNAJC6 and auxilin 2/GAK was performed with 
oligo-2 from the siGENOME SMARTpool (DNAJC6, no. D-009885-02) 
and an siGENOME SMARTpool (GAK, no. M-005005-02). Knockdown 
of CHC was performed with an ON-TARGETplus SMARTpool (CLTC; no. 
L-004001-01). Transfection of siRNA was achieved with Oligofectamine 
(Invitrogen), as described previously (Borner et al., 2006; Hirst et al., 2008). 
For single-hit knockdowns (72-h protocol), the final concentration of siRNA 
was 20 nM for clathrin depletion, and 30 nM (i.e., 15 nM + 15 nM) for 
auxilin 1 and auxilin 2 depletion. For double-hit knockdowns (96 h proto-
col), an additional second transfection was performed 48 h after the first 
hit. Control knockdowns were performed with a nontargeting siRNA (no. 
D-001810-10). The double-hit protocol was used for all immunofluores-
cence and microarray experiments. For the preparation of CCV fractions, 
both double- and single-hit protocols were used, as specified in Table S1.
Depletion of AP-4 was achieved with a combined AP-4 µ and AP-4  
knockdown, using ON-TARGETplus SMARTpools (AP4M1, no. L-011918-01; 
AP4E1, no. L-021474-00). Knockdown of C17orf56/tepsin was also per-
formed with an ON-TARGETplus SMARTpool (C17orf56, no. L-015821-02). 
For depletion of AP-4 and C17orf56/tepsin, a double-hit 96-h protocol 
was used. For the first hit, the final concentration of siRNA was 40 nM for 
AP-4 (20 nM AP4M1 + 20 nM AP4E1), and 30 nM for C17orf56/tepsin. 
48 h after the first hit, a second transfection at half the final concentration 
of siRNA was performed.
Antibodies and reagents
Western blot analysis and immunofluorescence microscopy were per-
formed with the following antibodies: AP-1  (mAb100/3; Sigma-Aldrich), 
AP-2  (AP.6, a gift from F. Brodsky, University of California, San Fran-
cisco, San Francisco, CA), AP-2  and AP-1  (anti-AP50; no. 611351; 
BD; this antibody recognizes both AP-2  and AP-1 , as verified by siRNA 
knockdown), AP-3 µ (Simpson et al., 1996), AP-4 ,  (for Western blot-
ting; Hirst et al., 1999), AP-4  (for immunofluorescence microscopy; no. 
612019; BD), auxilin 1 and auxilin 2/GAK (this antibody recognizes both 
auxilin 1 and 2, and was a gift from S. Sever, Harvard Medical School, 
Boston, MA; Newmyer et al., 2003), CALM (C18; Santa Cruz Biotechnol-
ogy, Inc.), CKAP5/chTOG (no. 86073; Abcam), CIMPR (1001; this anti-
body was a gift from P. Luzio, Cambridge Institute for Medical Research, 
Cambridge, England, UK), CHC/CHC17 (Simpson et al., 1996), EF-2 
(C-14; Santa Cruz Biotechnology, Inc.), GFP (3E6; MP Biomedicals), MHC-I 
(HC10; a gift from P. Lehner, Cambridge Institute for Medical Research), 
-myc epitope (9E10 and A14; Santa Cruz Biotechnology, Inc.), nonmus-
cle myosin 2 (Drenckhahn et al., 1983; the antibody was a gift from 
J. Kendrick-Jones, Medical Research Council Laboratory of Molecular 
Biology, Cambridge, England, UK), SNX9 (Hirst et al., 2003), TACC3 
(no. 56595; Abcam), VPS26 (Seaman, 2004), -tubulin (no. 18251; Abcam), 
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Bioinformatic profiling analysis
For analysis of proteins represented in all 10 SILAC sets, the ratio data 
were logarithmically transformed, centered, and decorrelated by PCA. 
Data transformation and PCA were performed with SIMCA-P+ 11.5 
(Umetrics), which was also used to generate the scatter plots in Figs. 3, 
S3, and S4. A Windows-compatible trial version of this program is freely 
available on the manufacturer’s website (http://www.umetrics.com/
simca). Table S4 contains the SILAC dataset and a simple step-by-step 
guide to recreating Fig. 3 with SIMCA-P+.
For automated cluster analysis, a reference set of 85 proteins was 
defined (Table S1). This set included subunits of six known protein com-
plexes (AP-1, AP-2, AP-3, AP-4, retromer, and the ribosome). Group as-
signment of candidate proteins was based on PCA to decorrelate the 
SILAC ratio data for the reference set. The algorithm was performed using 
custom software (“RefClus”) written in MATLAB 7 (MathWorks). RefClus is 
available online (Robinson, 2012). All SILAC ratio data were logarithmi-
cally transformed and then centered to the mean of the reference log data. 
For each candidate protein, the algorithm performed PCA of the reference 
set using only those SILAC sets in which the candidate protein was repre-
sented. The resulting reference PCA plots therefore varied for each combi-
nation of available data. In this way, each candidate protein was always 
represented in every SILAC set used for generating its corresponding refer-
ence plot. After confirmation of perfectly successful clustering of the refer-
ence data using the K-means iterative algorithm, the candidate data were 
projected on the principal components of the reference data (the number 
of principal components was variable because it depended on the avail-
able data). For each candidate protein, the squared Euclidean distance 
from each centroid of every reference cluster was calculated to assign each 
candidate protein to its nearest reference group. Proteins assigned to the 
AP-1 or AP-2 reference cluster were considered candidate CCV proteins. 
Only proteins that had at least four SILAC ratios, and were represented at 
least once under each experimental condition (clathrin kd, auxilin kd, or 
fractionation), were included in the automated cluster analysis. 1,523 pro-
teins matched these requirements (Table S1).
In addition to a cluster assignment, the automated analysis also pro-
vided the Euclidean distance (ED) of a candidate protein to the nearest 
(ED1) and second nearest (ED2) reference cluster, as well as the ratio ED2/ED1. 
A high ratio ED2/ED1 indicates that a protein is very clearly associated 
with only one reference cluster. An ED2/ED1 near 1 suggests that a protein 
is contested between the two closest reference clusters. This parameter was 
used to refine the primary output of the automated analysis:
First, there was a group of proteins that mapped to the space be-
tween AP-1 and AP-2. These could be recognized by their assignment to 
AP-1 as the closest and AP-2 as the second closest cluster, or vice versa. 
To identify which of these proteins were contested between AP-1 and 
AP-2 (i.e., not clearly associated with either one of them), we defined an 
ED2/ED1 <1.6 as a useful empirical cut-off. These proteins are annotated 
as AP1/AP2 in Table 1 and Table S2; they include several proteins 
known to be shared between AP-1– and AP-2–positive CCVs. Further-
more, Figs. 3 and S3 suggest that the cluster of known AP-1–associated 
proteins has an elongated shape that abuts the retromer cluster at the 
more central end. To define a boundary between the two clusters, we de-
termined which known retromer component was most distal to the ret-
romer reference cluster, and most proximal to the AP-1 reference cluster. 
This was the protein SNX6, with an EDAP1/EDRetromer of 1.92 (i.e., ap-
proximately twice as far away from AP-1 as from retromer). Any retromer-
assigned proteins with an EDAP1/EDRetromer <1.92 were reassigned to 
AP-1. Similarly, the six proteins contested between retromer and AP-2 
were reassigned to AP-2.
As a final quality control check, the profiles of all predicted CCV 
proteins were manually evaluated. Five proteins whose profiles were 
deemed inconclusive or only loosely similar to known CCV-associated pro-
teins were highlighted as “weak predictions” in Table S2.
The automated clustering was designed primarily to identify CCV 
proteins. To make predictions for the more central AP-4 and retromer clus-
ters, the stringency of the analysis had to be increased to yield a conserva-
tive (and therefore possibly less comprehensive) list of candidate retromer 
and AP-4–associated proteins. Only proteins with at least eight SILAC 
ratios were considered, and proteins with predicted transmembrane 
domains were excluded from the analysis.
All AP-4–assigned proteins were sorted by ED2/EDAP4; candidate AP-4 
proteins were expected to have high ratios. The lowest-ranking known 
AP-4 subunit was AP-4 , which was used to define the cut-off. Only proteins 
with a higher ED2/EDAP4 ratio than AP-4  were kept, leaving the four known 
AP-4 subunits and one new candidate AP-4–associated protein (Table 1).
LC-MSMS
Tryptic peptides were dried almost to completion in a centrifugal vacuum 
concentrator (Eppendorf) and resuspended in 10 µl MS solvent (0.1% 
[vol/vol] TFA and 3% [vol/vol] MeCN). Peptides were analyzed using an 
LTQ-OrbiTrap XL (Thermo-Fisher Scientific) coupled to a nanoAcquity uPLC 
(Waters). The uPLC was equipped with a trap column (Symmetry, 180 µm × 
20 mm, 5 µm; Waters) and an analytical column (BEH 130, 75 µm × 
250 mm, 1.7 µm; Waters) with mobile phase solvent A (0.1% vol/vol 
formic acid) and solvent B (100% MeCN).
3 µl of tryptic peptides was injected onto the trap column and 
washed for 3 min at 10 µl/min 99.9% solvent A and 0.1% solvent B. 
Peptides were eluted to the analytical column and resolved using a variety 
of gradient methods with the optimum method rising from 3 to 25% solvent 
B over 90 min, to 40% by 110 min, and to 85% by 115 min. Eluting 
peptides were sprayed using a 10 µm PicoTip emitter (New Objective) at 
a spray voltage of 2.3 kV. MS spectra were acquired between m/z 400 
and 1,700 at 60,000 resolution (fwhm at m/z 400). Where lock mass 
was enabled, the polydimethylcyclosiloxane ions (m/z 445.120025) 
were used. MS to MSMS switching was controlled in an automatic data-
dependent acquisition (DDA) fashion with MSMS spectra acquired in the 
LTQ at a normalized collision energy of 35%. Ions selected for MSMS 
were excluded from further fragmentation for up to 120 s. All samples 
were run in duplicate.
Raw files were processed using MaxQuant version 1.0.13.13 (Cox 
and Mann, 2008) and Mascot v.2.3.0 (Matrix Science). Data were 
searched against the International Protein Index (IPI) human database 
(v.3.68) with a concatenated reversed decoy database. Cam (C) was se-
lected as a fixed modification, and oxidized (M), acetyl (Protein N-term), 
and deamidation (NQ) were selected as variable modifications. Peptide 
and protein false discovery rate (FDR) were both set to 0.01 and a mini-
mum peptide length of six was required. Ratio calculations were performed 
on razor and unique peptides with requantify on and a minimum ratio 
count of 1.
To determine the incorporation efficiency of heavy amino acids, 
lysates from metabolically labeled cells were prepared, trypsin digested, 
and analyzed by LC-MSMS. Raw files were processed using MaxQuant 
version 1.0.13.13 with the requantify function turned off. Output Peptides.
txt files were processed using the R statistical package (R Foundation for 
Statistical Computing) to generate density plots illustrating incorporation 
rate. Mean incorporation efficiency was 97%.
For the mass spectrometric analysis in Fig. 8 H, proteins were di-
gested in-gel with trypsin, and peptides were eluted to an LTQ-OrbiTrap 
XL using a 50-min gradient. DDA collision-induced dissociation (CID) data 
were acquired and raw files were exported to Proteome Discoverer 1.2, 
processed, and searched against the IPI human database v.3.68 using 
Sequest. Deamidation (N,Q) and oxidation (M) were allowed as potential 
variable modifications and carbamidomethylation (C) as a fixed modifica-
tion. A decoy search was performed and an FDR threshold of 1% imposed 
with reported proteins requiring a minimum of two peptides.
Processing of quantitative mass spectrometry data
The primary MaxQuant output for each SILAC comparison of CCV frac-
tions was a list of identified proteins, a ratio of relative abundance of each 
protein in the two compared samples (heavy over light label = ratio H/L), 
and the number of quantification events (observed peptides) that the ratio 
calculation was based on. Each MaxQuant output file was formatted in an 
identical manner: Proteins with no gene name were removed. Proteins with 
(non-normalized) ratios >50 or <0.02 were removed, as these were out-
side the theoretical range that could be observed with a SILAC labeling 
efficiency of <98%. In the case of duplicate entries for the same protein, the 
entry with the smaller number of quantification events was deleted. Ratios 
were linearly normalized assuming equal protein quantities in both heavy 
and light labeled samples (Borner et al., 2006). The number of quantifica-
tion events was used to weight the contribution of individual proteins. In 
brief, the ratio H/L of each protein was converted into two fractions, FH 
and FL, which add up to 1 (formula: FH = [H/L]/[1 + H/L]; FL = 1/[1+H/L]). 
Each fraction was multiplied with the number of quantification events for 
the corresponding protein as an estimated measure of its relative contribu-
tion to protein loading. All multiplied FH and FL values were summed up to 
obtain total FH and total FL. The ratio of total FH over total FL is an estimate 
of the protein quantity present in the heavy sample relative to the light sam-
ple. If both samples were evenly loaded, the ratio was one. Otherwise, the 
ratio of total FH over total FL was used to normalize the original H/L ratios 
by division. Normalization adjustments were generally small (<20% for 
most datasets, 17.6% on average for all datasets). Table S1 lists the com-
plete processed SILAC data used in this study.
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Images were analyzed and adjusted for brightness and contrast in Photoshop 
CS4 (Adobe).
To localize epitope- or GFP-tagged proteins, cells were transfected 
with the appropriate expression vectors 24–48 h before imaging, using 
HeLa Monster transfection reagent (Mirus Bio LLC).
For the analysis of micronuclei frequency, control and siRNA-
treated Hela cells were seeded into 96-well plates at a range of densities 
on day four of the five-day (96 h) transfection protocol. On day five, the 
cells were fixed with 3.3% (vol/vol) formaldehyde in PBS, permeabilized 
in 0.1% (vol/vol) Triton X-100, and stained with 0.4 ng/ml Hoechst 
33342 (Invitrogen) for 40 min at room temperature. The nuclei were imaged 
with an ArrayScan VTI microscope (Cellomics/Thermo-Fisher Scientific) 
equipped with a camera (ORCA-ER; Hamamatsu Photonics), using a 20× 
0.4 NA objective lens (Carl Zeiss) and the XF100 Hoechst filter. (The 
fields shown in Fig. 7 E were imaged with a Carl Zeiss 40× 0.5 NA ob-
jective lens.) 3–10 wells per condition were imaged in each experiment. 
The nuclei and micronuclei identification was performed using the propri-
etary Micronucleus Bioapplication software (Cellomics/Thermo-Fisher 
Scientific); quantitative analysis was performed within the R statistical 
package (R Foundation for Statistical Computing). Sparse (<70 cells) or 
over-confluent (>120 cells) fields were excluded from the analysis, and a 
fold increase in percentage of cells with at least one micronucleus relative 
to cells treated with nontargeting siRNA was calculated for each condi-
tion. Statistical analysis was performed using one-way analysis of vari-
ance (ANOVA) with Tukey-Kramer’s multiple comparison post-test, within 
Prism 5.0 (GraphPad Software).
Live cell imaging
Movies were captured using a spinning disk microscope (Cell Observer SD; 
Carl Zeiss) equipped with a 63× 1.4 NA objective lens, a charge-coupled 
device camera (AxioCam MR), and AxioVision software v4.8 (Carl Zeiss). All 
imaging was performed at 37°C. Image sequences were processed with 
AxioVision software, and QuickTime Pro (Apple). For Video 1, a z stack of 
five optical sections (thickness 1 µm/slice) was imaged every 2.6 s over a 
period of 175 s (67 stacks in total). Z stacks were collapsed into maximum 
intensity projections, and rendered at 15 frames per second (40× acceler-
ated). Live cell imaging was performed on a HeLa cell line that stably expresses 
the tepsin-GFP construct described in “Constructs for transient expression.”
Western blot analysis
SDS-PAGE and Western blot analysis were performed according to 
standard protocols. The positions of protein molecular weight markers 
(PageRuler Plus, Fermentas/Thermo-Fisher; BenchMark Protein Ladder, 
Invitrogen) are indicated in Figs. 1, 7, 8, S1, and S2. In some panels, the 
approximate apparent molecular weights of proteins are shown instead 
(indicated by ); they were estimated by comparison with the migration 
of molecular weight markers. Please note that these values represent repro-
ducible averages from multiple experiments (n ≥ 3), and in some cases 
deviate considerably from the predicted molecular weights of the proteins. 
In Fig. 7 B, the loading was 13 µg/lane (lysates), 2 µg/lane (CCV fractions); 
i.e., 6.5:1. In Fig. 8 F, the loading was 8 µg/lane (postnuclear supernatant 
[PNS]), 1.6 µg/lane (coated vesicle fractions); i.e., 5:1.
Bioinformatic analysis of tepsin
To look for tepsin homologues, Basic Local Alignment Search Tool (BLAST) 
searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi) were performed using the 
C17orf56 sequence (GenBank/EMBL/DDBJ accession no. NP_653280.1). 
Organisms belonging to all five eukaryotic supergroups were searched: 
Homo sapiens (Opisthokonta), Dictyostelium discoideum (Amoebozoa), 
Arabidopsis thaliana (Archaeplastida), Trypanosoma brucei (Excavata), 
and Plasmodium falciparum (Stramenopila, Alveolata, and Rhizaria 
[SAR]/Cryptophyta, Centrohelida, Telonemia, and Haptophyta [CCTH]). 
Previous studies had shown that all five of these organisms have AP-4 
genes (Field et al., 2007). Tepsins were found in all five; the GenBank/
EMBL/DDBJ accession nos. are NP_653280, XP_641657, NP_566540, 
XP_822540, and XP_001348743, respectively. When each of the non-
human sequences was used in BLAST searches of the National Center for 
Biotechnology Information human protein database, the top hit in every 
case was tepsin. HHpred (http://hhpred.tuebingen.mpg.de/hhpred) was 
used to look for structural similarities with other proteins. All five proteins 
were predicted to contain an ENTH domain at the N terminus, as well as 
a second -helical domain, related to both VHS and ENTH domains, in the 
middle of the sequence. The sequences were also analyzed using Jpred 
(Cole et al., 2008; http://www.compbio.dundee.ac.uk/www-jpred/) and 
predicted to be mainly unstructured outside of the two -helical domains.
Proteins assigned to the retromer cluster were sorted by ED2/EDRetromer, 
and the known retromer subunit with the lowest ratio was used as a cut-off 
(SNX6). Only proteins with higher ratios were considered candidate ret-
romer-associated proteins. As a further stringency filter, proteins represented 
in all 10 SILAC sets were sorted by absolute distance to the retromer refer-
ence cluster; again, SNX6 was the known retromer subunit with the great-
est distance. Proteins that were further away from the retromer reference 
cluster than SNX6 were discarded. The result was a list of 10 known and 
five new predicted retromer proteins (Table 1).
It is important to note that absolute distance measurements are only 
comparable between proteins when their corresponding reference PCA 
plots are identical (which is the case for proteins present in all 10 SILAC 
sets). For CCV predictions, proteins with 4–10 SILAC ratios were ana-
lyzed, and PCA reference plots were accordingly divergent. Therefore, ab-
solute distances to reference clusters were not compared between candidate 
CCV proteins. In contrast, the ED2/ED1 ratio is independent of reference 
plot shape, and was hence used as a tool to refine CCV predictions.
Estimation of relative protein abundance
The SILAC data were used to calculate exponentially modified protein 
abundance indices (emPAIs) for proteins present in the CCV enriched frac-
tion. emPAI is an approximate measure of protein abundance (Ishihama 
et al., 2005). Here, a modified version of emPAI was used, as recently de-
scribed by Ohta et al. (2010). This modified emPAI is based on spectral 
counts rather than the number of unique peptides, and is hence particularly 
suitable for large SILAC datasets. For each protein, emPAI was calculated 
as follows: emPAI = (10[spectral count/MW]) 1.
MW is the molecular weight of the protein. The spectral count is de-
rived from the number of peptides observed for the protein, and the num-
ber of times that each peptide was observed (Table S1).
Because clathrin and auxilin depletion affect the abundance of CCV 
proteins, only SILAC datasets from fractionation experiments (i.e., no 
knockdown) were used to calculate emPAIs (datasets F1, F2, and F4*; 
dataset F3 was excluded because it was part of a triple-labeling experiment 
that included an auxilin knockdown). emPAI values were calculated only 
for proteins that were identified in all three of these experiments to obtain 
robust means. Hence, Fig. 6 shows the relative abundance of major CCV 
coat components; further coat proteins are present in trace amounts. In ad-
dition, only well-established CCV proteins were included in Fig. 6.
To calculate emPAIs of AP complexes, the means of the AP-1  and 
AP-1  subunits were used for AP-1, and the means of the AP-2  (isoforms 
1 + 2) and AP-2  subunits were used for AP-2. The -subunits were not in-
cluded, as they are partially shared between AP-1 and AP-2. Peptide data 
were insufficient to include the AP-2  subunit.
The usefulness of emPAI as a tool to estimate protein abundance has 
been demonstrated convincingly (e.g., Ohta et al., 2010). Nevertheless, 
the accuracy of emPAI-based quantification is thought to be within 70% 
of the actual value (Ishihama et al., 2005). Because of this relatively large 
margin of error, the analysis shown in Fig. 6 should be regarded as a 
rough estimate of the HeLa CCV coat stoichiometry.
Constructs for transient expression
FAM84B and C10orf88 were amplified by PCR from IMAGE clones 
5262890 and 5519534, respectively. The 3 primers included a sequence 
encoding a single myc tag. The amplified and tagged cDNAs were cloned 
into the expression vector pIRESneo2 (Takara Bio Inc.). C17orf56/tepsin 
was amplified from an IMAGE clone (5430837) by PCR, and cloned in-
frame into pEGFP-N3 (Takara Bio Inc.). The sequence of all constructs re-
ported here was verified by PCR. Expression-ready C-terminally myc-tagged 
BMP2K was purchased from OriGene (no. RC215795). The murine 
DENND4C-GFP construct was as a gift from F. Barr (University of Oxford, 
Oxford, England, UK; see Yoshimura et al., 2010).
Fluorescence microscopy and analysis of micronuclei frequency
For immunofluorescence microscopy, cells where either fixed in methanol 
at 20°C or fixed in 3% formaldehyde in PBS (137 mM NaCl, 2.7 mM 
KCl, 10 mM Na2HPO4, and 1.76 mM KH2PO4, pH 7.4) at room tempera-
ture and permeabilized with 0.1% (vol/vol) Triton X-100 (in PBS). For some 
experiments, cells were pre-permeabilized with 0.05% (wt/vol) saponin (in 
PBS) for 10–15 s before fixation. Proteins were detected with primary and 
secondary antibodies listed under “Antibodies and reagents.” Fluores-
cence microscopy was performed with an Axiovert 200M microscope 
(Carl Zeiss), equipped with a 63× 1.4 NA objective lens and a charge-
coupled device camera (Orca AG; Hamamatsu Photonics), and controlled by 
OpenLab software version 5.5 (Cellular Imaging and Analysis; Perkin Elmer). 
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2% paraformaldehyde/2.5% glutaraldehyde (0.1 M sodium cacodylate 
buffer, pH 6.5) for 1 h at room temperature. The pellet was postfixed with 
1% osmium tetroxide in 0.1 M sodium cacodylate buffer, pH 7.3, en bloc 
stained with 0.5% uranyl acetate in 0.05 M sodium maleate buffer pH 5.2 
for 1 h, dehydrated in ethanol, and embedded in Araldite CY212 epoxy 
resin (Agar Scientific). Ultrathin sections (60–70 nm) were stained with 
uranyl acetate and Reynolds lead citrate, and viewed in a transmission 
electron microscope (model CM 100; Philips).
Microarray gene expression analysis
Microarray analysis was performed by the Cambridge Genomic Ser-
vices (Cambridge, England UK) using an Illumina HumanHT-12 v4 Ex-
pression BeadChip.
PCA: A brief introduction
Contemporary high-throughput techniques such as gene array expression 
analyses or large-scale quantitative proteomic screens produce datasets of 
considerable complexity. In most cases, the data can be tabulated as a 
matrix consisting of rows of different observations, with each variable 
heading a column. An example of this is Table S1, which contains 2,527 
proteins (observations) whose change in abundance was measured across 
10 SILAC experiments (variables). Such data matrices are difficult to inter-
pret without further processing. Each variable can be depicted as a single 
axis, but plotting individual variables against each other is practically limited 
to two or three dimensional representations, which reflect only a small pro-
portion of multidimensional data. However, several computational meth-
ods are available to transform multivariate datasets into a more manageable 
format. The purpose of the transformation is to represent the information 
contained in the dataset in a way that allows the simple identification of 
underlying trends (“cluster analysis”; see Janes and Yaffe [2006] for an 
accessible review on the subject).
PCA can decrease the dimensionality of data by removing redun-
dant linear correlations that exist between variables. If the behaviour of 
two or more variables is closely linked, their combined contribution to the 
distribution of the data may be represented using a single new composite 
variable that weights the optimal contributions from each original variable. 
A simple example of this is the repeat experiments of the same experi-
mental condition, which are likely to show a high degree of correlation 
(covariance). They may therefore be “collapsed” into a derived variable 
that more or less reflects the underlying trend of this condition. But PCA 
also detects weak or partial correlations between seemingly unrelated ex-
perimental conditions.
To derive new composite variables and thus reduce the dimensional-
ity of the data, PCA determines the orthogonal directions of covariances, 
in order of statistical relevance. These directions are vectors called principal 
components (PCs); they define the orientation of the new super-axes that 
describe the reduced dataspace. Two or three PCs are often sufficient to 
account for most of the variability in the data. Each “observation” (e.g., 
protein) is associated with a row of measurements, which constitutes its 
data vector. By multiplying each data vector with a principal component 
vector, a new composite variable is obtained, which is called a z score. 
The z score indicates the position of an observation projected along the 
corresponding principal component. Each z score is thus a super-variable that 
combines weighted levels of input from the original variables. Because all 
principal component vectors are orthogonal, the z scores themselves are 
free of linear correlations.
Each principal component explains only a proportion of the covari-
ance in the data, with the greatest contribution from PC1, and decreasing 
contributions from each higher-order principal component. Therefore, the 
first two or three z scores are usually combined into a “scores plot” for data 
evaluation and cluster analysis. Fig. 3 is an example of this: for each pro-
tein, the z scores of PC1 versus PC2 were plotted. Proteins that are strongly 
affected by the experimental conditions have large (positive or negative) 
scores, placing them in the periphery of the plot. Importantly, proteins that 
show similar behaviour across the 10 SILAC experiments have similar sets 
of scores, and therefore cluster. Three-dimensional scores plots, such as 
Fig. S4, may confer higher discriminating power, but are often impractical 
to illustrate in print for large datasets.
Online supplemental material
Fig. S1 shows how analysis of the CCV-enriched fraction by electron 
microscopy allows the design of an improved preparation protocol. Fig. S2 
shows a microarray gene expression analysis of clathrin- and auxilin- 
depleted cells. Fig. S3 shows how PCA reveals clustering of CCV and non-
CCV proteins into functional groups (a fully annotated version of Fig. 3). 
Fig. S4 shows a three-dimensional PCA scores plot that reveals a novel 
Cell lines for AP-4 experiments
Human fibroblasts from control and AP-4–deficient patients were obtained 
from G. Mancini (Erasmus Medical Center, Rotterdam, Netherlands; 
AP4M1*), L. Colleaux (Fondation IMAGINE, Université Paris Descartes, 
Paris, France; AP4B1*), and A. Raas-Rothschild (Hadassah Hebrew Univer-
sity Medical Center, Jerusalem, Israel; AP4B1*). Both mutations cause very 
similar phenotypes, including severe intellectual disability, as has been 
described previously (Verkerk et al., 2009; Abou Jamra et al., 2011). 
The similarity of the patient phenotypes suggests that both mutations equally 
disrupt the AP-4 pathway.
The mutation in the AP4B1 gene is an insertion in exon 5, result-
ing in an early premature stop codon (amino acids 163–739 missing), 
which causes mRNA instability (Abou Jamra et al., 2011). Any residual 
truncated AP4B1* protein (162 amino acids) is likely to be completely 
nonfunctional, and unstable.
The mutation in the AP4M1 gene (Verkerk et al., 2009) is a transver-
sion in intron 14, which results in the skipping of exon 14, causing a late 
premature stop codon. The resulting truncated AP4M1* protein misses the 
C-terminal 112 (out of 453) amino acids. This truncated mutant AP4M1* 
is undetectable by Western blotting (Verkerk et al., 2009), which sug-
gests that it is nonfunctional and unstable. Our immunoprecipitation data 
(Fig. 8 E) suggest however that some mutant AP4M1* protein can still 
inefficiently assemble into an AP-4 complex. This mutant AP-4 appears to 
be nonfunctional, as indicated by the patient phenotype, and our immuno-
fluorescence data (Fig. 8 D).
Fibroblasts were cultured in DME (Sigma-Aldrich) supplemented 
with 10% (vol/vol) fetal calf serum (Sigma-Aldrich) and antibiotics, as de-
scribed for HeLa cells (see “Cell culture, metabolic labeling, and siRNA-
mediated knockdowns”). Primary cortical neurons from embryonic rats 
were prepared and provided by C. Freeman (Cambridge Institute for Med-
ical Research, Cambridge, England, UK).
Coated vesicle preparations for AP-4 experiments
Coated vesicle enriched fractions were prepared exactly as CCV fractions, 
but the final pelleting step was performed at 86,900 g RCFmax (40,000 
RPM, TLA-110) for 30 min, which results in slightly higher enrichment of 
non-CCVs.
Immunoprecipitations and GST pull-downs
For immunoprecipitations of AP-4 , cell were lysed in PBS-N (137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.76 mM KH2PO4, and 1% [vol/vol] 
IGEPAL CA-630 [Sigma-Aldrich], pH 7.4). Lysates were cleared by cen-
trifugation. Immunoprecipitated complexes were recovered with protein 
A–Sepharose (no. 17-0780-01; GE Healthcare). See Hirst et al. (1999) for 
a more detailed protocol. For AP-4 pull-downs, DNA fragments encoding 
the “ear” domains of AP-4  and AP-4  were amplified from cDNA (from 
IMAGE clone 2906087, and RZPD clone DKFZp686L12167Q, respec-
tively), and cloned into vector pGEX 4T1 (GE Healthcare). N-terminal GST 
fusions of the  and  ear domains were expressed in E. coli. The ear 
domains had the following sequences: AP-4 , aa 598–739, GPLIPEE-
NKERVQELPDSGALMLVPNRQLTADYFEKTWLSLKVAHQQVLPWRGEFH-
PDTLQMALQVVNIQTIAMSRAGSRPWKAYLSAQDDTGCLFLTELLLEPGN-
SEMQISVKQNEARTETLNSFISVLETVIGTIEEIKS; AP-4 , aa 881–1,135, 
MEIFHPPQSTAASVAKESSLASSFLEETTEYIHSNAMEVCNNETISVSSYKIW-
KDDCLLMVWSVTNKSGLELKSADLEIFPAENFKVTEQPGCCLPVMEAESTK-
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